Extrahepatic malignancies in a liver transplant recipient from a living related donor
Open Access
- 10 September 2020
- journal article
- Published by IPO Association of Transplantologists in Transplantologiya
- Vol. 12 (3), 199-212
- https://doi.org/10.23873/2074-0506-2020-12-3-199-212
Abstract
Background. Cancer occurring in recipients of living donor liver transplantation may be characterized by a progressive course requiring an immediate specialized treatment initiation and adjustment of immunosuppression regimen. Aim. To specify the malignancy development mechanisms and risk factors in the recipients of living donor liver transplantation. Material and methods: 275 living donor liver transplantations were made in Burnasyan Federal Medical Biophysical Center of FMBA from 2010 to 2020. Forty two (15.27 %) patients underwent surgery for hepatocellular carcinoma. The median time to the onset of malignancy development was estimated. The incidence of malignancy in general population and in recipients of living donor liver transplantation was compared. Results. The development of neoplastic lesion was registered in 9 cases (3.27%). Malignances were detected in 8 cases (2.90%). Median time to the onset of malignancy development was 48 months. 1, 3, and 5 year overall survival rates were 97%, 96%, 94%;respectively; 1, 3, and 5 year survival rates after transplantation for hepatocellular cancer were 97%, 91%, 91% respectively. Survival rate of patients with De-novo malignancy was 90%. Conclusion. Recipients of living donor liver transplantation have an increased risk of malignancy development that requires a close long-term follow-up.Keywords
This publication has 29 references indexed in Scilit:
- Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients DatabasePLOS ONE, 2016
- Donor transmitted andde novocancer after liver transplantationWorld Journal of Gastroenterology, 2014
- Cancer Transmission From Organ Donors—Unavoidable But Low RiskTransplantation, 2012
- Donor-Transmitted Malignancy in a Liver Transplant Recipient: A Case Report and Review of LiteratureDigestive Diseases and Sciences, 2012
- Donor-transmitted metastasis of colorectal carcinoma in a transplanted liverTransplant International, 2011
- Gestational Choriocarcinoma Transmission Following Multiorgan DonationAmerican Journal of Transplantation, 2010
- Donor derived malignancy following transplantation: a reviewCell and Tissue Banking, 2007
- Maintenance Immunosuppression with Target-of-Rapamycin Inhibitors is Associated with a Reduced Incidence of De Novo MalignanciesTransplantation, 2005
- Cancer risk after renal transplantation in the nordic countries, 1964–1986International Journal of Cancer, 1995
- DONOR-TRANSMITTED TUMORS IN LUNG ALLOGRAFT RECIPIENTSTransplantation, 1994